Market Research Logo

Global Fibromyalgia Drugs Market 2015-2019

Global Fibromyalgia Drugs Market 2015-2019

About Fibromyalgia

According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, fibromyalgia is a syndrome with an unknown cause and chronic pain and muscle tenderness as the major symptoms. Unlike arthritis, it does not cause joint, muscle or other tissue inflammation. However, fibromyalgia is known to cause impairment of joints, soft tissues, and causes significant pain and fatigue. Fibromyalgia affects women more than men. In the US, the condition affects more than 5 million people aged 18 years and above, of which 80-90% are women. There is no particular diagnostic test for detecting fibromyalgia, and physicians undertake differential diagnosis to check the presence of the syndrome. Currently in the US, only three drugs are approved to treat fibromyalgia. Off-label treatment is a popular option to treat fibromyalgia using analgesics, antidepressants, sedatives, neuroleptics, and muscle relaxants.

Technavio's analysts forecast the global fibromyalgia drugs market to grow at a CAGR of 0.79% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global fibromyalgia drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of fibromyalgia. Based on the chemical class of the drugs used to treat fibromyalgia, the market is segmented as follows:

  • Serotonin norepinephrine reuptake inhibitors
  • GABA analogs
  • Others
Technavio's report, the Global Fibromyalgia Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. This report includes a discussion of the market in the following three regions:
  • Americas: The major countries here are the US, Canada, Mexico, and Brazil
  • EMEA: The major countries here are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
  • APAC: The major countries here are Japan, China, Australia, Singapore, South Korea, and India.
  • APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.Key Regions
  • Americas
  • APAC
  • EMEA
Key Vendors
  • Actavis
  • Eli Lilly
  • Pfizer
Other Prominent Vendors
  • Daiichi Sankyo
  • Innovative Med Concepts
  • Meda
  • Meiji Seika
  • Merck Sharp and Dohme
  • Switch Biotech
  • Theravance
  • Tonix
  • Zynerba Pharmaceuticals
Key Market Driver
  • Unmet Medical Needs
  • For a full, detailed list, view our report
Key Market Challenge
  • Adverse Events
  • For a full, detailed list, view our report
Key Market Trend
  • Expected Entry of Me-too Drugs
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Fibromyalgia Drugs Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Fibromyalgia Drugs Market: Actavis, Eli Lilly and Pfizer

Other Prominent Vendors in the market are: Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Merck Sharp and Dohme, Switch Biotech, Theravance, Tonix and Zynerba Pharmaceuticals

Commenting on the report, an analyst from Technavio’s team said: “Pharmaceutical companies carry out small molecular changes on existing drugs and market them as me-too drugs. Vendors produce me-too drugs because of the increased expenditure associated with drug development and to overcome cost barriers. For instance, the CR formulation of Lyrica from Lyrica (pregabalin) by Pfizer is in phase III clinical trials. DS-5565 (mirogabalin) by Daiichi Sankyo is a me-too drug that is undergoing phase III clinical trials. These drugs are likely to be introduced in the market during the forecast period.”

According to the report, though fibromyalgia has no known cure, approved drugs such as Lyrica, Savella, and Cymbalta are currently used to provide symptomatic treatment, especially in the US. The market presents immense potential for pharmaceutical companies to invest in the R&D of drugs that can cure the condition. In addition, Cymbalta and Lyrica have several adverse effects that lead to noncompliance and drug regimen discontinuation among individuals with the condition. In EMEA and APAC, healthcare settings and patients opt for off-label and OTC drugs to treat the condition. These drugs also have severe side effects. This provides vendors with a huge opportunity to develop drugs that have a better safety and efficacy profile.

Further, the report states that adverse effects of drugs leads to a reduction in the sales and revenue of the drugs and a decline in the market value.

Companies Mentioned

Actavis, Eli Lilly, Pfizer, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Merck Sharp and Dohme, Switch Biotech, Theravance, Tonix, Zynerba Pharmaceuticals

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Product Profiles
    • Savella
      • Cymbalta
      • Lyrica
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Disease Overview
    • Understanding the Disease
    • Signs and Symptoms
      • Pain and Muscle Stiffness
      • Sleep Disturbances
      • Fatigue
      • Chronic Headache
      • Other Symptoms
    • Epidemiology
      • Table Epidemiology of Fibromyalgia 2014-2019
    • Pathophysiology
      • Table Pathophysiology of Fibromyalgia
    • Economic Burden
    • Novel Therapeutic Approach
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global Fibromyalgia Drugs Market 2014-2019 ($ millions)
      • Table Global Fibromyalgia Drugs Market: Key Takeaways
    • Fibromyalgia Drugs Market in US
      • Market Overview
      • Market Size and Forecast
        • Table Fibromyalgia Drugs Market in US 2014-2019 ($ millions)
    • Fibromyalgia Drugs Market in Europe
      • Market Overview
      • Market Size and Forecast
        • Table Fibromyalgia Drugs Market in Europe 2014-2019 ($ millions)
    • Five Forces Analysis
  • Market Segmentation by Chemical Class of Drug
    • Global Fibromyalgia Drugs Market by Chemical Class of Drug 2014-2019
      • Table Global Fibromyalgia Drugs Market by Chemical Class of Drug
    • Serotonin-norepinephrine Reuptake Inhibitors
    • GABA Analogs
    • Others
  • Geographical Segmentation
    • Global Fibromyalgia Drugs Market by Geography 2014-2019
      • Table Global Fibromyalgia Drugs Market by Geography 2014
  • Buying Criteria
  • Pipeline Portfolio
    • Table Fibromyalgia: Pipeline Portfolio
    • Key Information on Pipeline Candidates
      • TNX-102 SL
      • Lyrica CR
      • DS-5655
      • TD-9855
      • IMC-1
      • Mirtazapine
      • Flupirtine
      • SWT06101
      • ZYN001
  • Market Growth Drivers
    • Table Major Drivers of Global Fibromyalgia Drugs Market
  • Drivers and Their Impact
  • Market Challenges
    • Table Major Challenges in Global Fibromyalgia Drugs Market
  • Impact of Drivers and Challenges
  • Market Trends
    • Table Major Trends in Global Fibromyalgia Drugs Market
  • Trends and Their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Major Vendor Analysis 2014
      • Table Global Fibromyalgia Drugs Market: Vendor Ranking
      • Pfizer
        • Table Pfizer: YoY Global Revenue of Lyrica 2010-2014 ($ millions)
        • Table Pfizer: Key Takeaways
      • Eli Lilly
        • Table Eli Lilly: YoY Global Revenue of Cymbalta 2010-2014 ($ millions)
        • Table Eli Lilly: Key Takeaways
      • Actavis
        • Table Actavis: YoY Global Revenue of Savella 2010-2013 ($ millions)
        • Table Actavis: Key Takeaways
    • Other and Future Prominent Vendors
  • Key Vendor Analysis
    • Actavis
      • Key Facts
      • Business Description
      • Business Segmentation
        • Table Global Fibromyalgia Drugs MarketBusiness Segmentation 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Global Fibromyalgia Drugs Market Business Segmentation by Revenue 2012 and 2013 ($ millions)
      • Sales by Geography
        • Table Actavis : Sales by Geography ($ millions)
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Eli Lilly
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue
        • Table Eli Lilly: Business Segmentation by Revenue 2013
        • Table Eli Lilly: Business Segmentation by Revenue 2012 and 2013 ($ millions)
      • Sales by Geography
        • Table Eli Lilly: Sales by Geography 2013
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Pfizer
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table Pfizer: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
      • Geographical Segmentation by Revenue 2014
        • Table Pfizer: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Key Developments
      • SWOT Analysis
  • Other Reports in This Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report